GSK (NYSE:GSK) reported that a study showed its drug belantamab mafodotin was able to reduce the risk of death by 42% in patients with multiple myeloma at or after first relapse.

GSK (NYSE:GSK) announced Tuesday that its shingles vaccine, Shingrix, reduced the risk of dementia with a statistically significant effect compared to Merck's (MRK) pneumonia vaccine, Pneumovax 23 ...

Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased GSK plc. ("GSK" or the ...